Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn R, Buzina R et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Prev Med. 1995; 24: 308–315.
Yamagishi K, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 965–974.
de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015; 02: 04.
Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7: e1000252.
Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91: 535–546.
Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S et al. Diet, serum cholesterol, and death from coronary heart disease. N Engl J Med 1981; 304: 65–70.
Mirmiran P, Ramezankhani A, Azizi F. Combined effects of saturated fat and cholesterol intakes on serum lipids: Tehran Lipid and Glucose Study. Nutrition 2009; 25: 526–531.
Samuelson G, Bratteby L, Mohsen R, Vessby B. Dietary fat intake in healthy adolescents: inverse relationships between the estimated intake of saturated fatty acids and serum cholesterol. Br J Nutr 2001; 85: 333–341.
Otto MCdO, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi‐ethnic study of atherosclerosis. J Am Heart Assoc 2013; 2: e000092.
Sjogren P, Rosell M, Skoglund-Andersson C, Zdravkovic S, Vessby B, de Faire U et al. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J Nutr 2004; 134: 1729–1735.
Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr 2013; 109: 718–726.
Garg ML, Thomson ABR, Clandinin MT. Interactions of saturated, n-6 and n-3 polyunsaturated fatty acids to modulate arachidonic acid metabolism. J Lipid Res 1990; 31: 271–277.
MacDonald-Wicks LK, Garg ML. Incorporation of n-3 Fatty Acids into Plasma and Liver Lipids of Rats: Importance of Background Dietary Fat. Lipids 2004; 39: 545–551.
Keys A, Anderson JT, Grande F. Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet 1957; 273: 959–966.
Ahrens EH, Insull W, Blomstrand R, Hirsch J, Tsaltas T, Peterson M. The influence of dietary fats on serum lipid levels in man. Lancet 1957; 1: 944–953.
Shepherd J, Packard CJ, Grundy SM, Yeshurun D, Gotto J, Antonio M. et al. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res 1980; 21: 91–99.
Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013; 346.
Liou YA, Innis SM. Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-γ-linolenic and eicosapentaenoic acid in plasma of adult men. Prostaglandins Leukotrienes Essent Fatty Acids 2009; 80: 201–206.
Novak EM, Dyer RA, Innis SM. High dietary ω-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 2008; 1237: 136–145.
Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009; 77: 937–946.
Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984; 779: 89–137.
Eslick GD, Howe PRC, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol 2009; 136: 4–16.
Dawczynski C, Massey KA, Ness C, Kiehntopf M, Stepanow S, Platzer M et al. Randomized placebo-controlled intervention with n-3 LC-PUFA supplemented yoghurt: Effects on circulating eicosanoids and cardiovascular risk factors. Clin Nutr 2013; 32: 686–696.
Lepage G, Roy GC. Direct trans-esterification of all classes of lipid in an onestep reaction. J Lip Res 1986; 27: 114–120.
Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am J Clin Nutr 2002; 75: 668–675.
Micallef MA, Garg ML. The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr 2008; 138: 1086–1090.
Garg ML, Wierzbicki AA, Thomson ABR, Clandinin MT. Dietary saturated fat level alters the competition between α-linolenic and linoleic acid. Lipids 1989; 24: 334–339.
Mori TA, Vandongen R, Beilin LJ, Burke V, Morris J, Ritchie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994; 59: 1060–1068.
Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L et al. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis 2003; 167: 149–158.
Fernandez ML, West KL. Mechanisms by which dietary fatty acids modulate plasma lipids. J Nutr 2005; 135: 2075–2078.
Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010; 68: 155–167.
Milte CM, Coates AM, Buckley JD, Hill AM, Howe PRC. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 2008; 99: 1083–1088.
Mori TA, Burke V, Puddey IB, Watts GF, O’Neal DN, Best JD et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000; 71: 1085–1094.
Mustad VA, Ellsworth JL, Cooper AD, Kris-Etherton PM, Etherto TD. Dietary linoleic acid increases and palmitic acid decreases hepatic LDL receptor protein and mRNA abundance in young pigs. J Lipid Res 1996; 37: 2310–2323.
Wilkinson J, Higgins JA, Fitzsimmons C, Bowyer DE. Dietary fish oils modify the assembly of VLDL and expression of the LDL receptor in rabbit liver. Arterioscler Thromb Vasc Biol 1998; 18: 1490–1497.
Ishida T, Ohta M, Nakakuki M, Kami H, Uchiyama R, Kawano H et al. Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: participation of cholesterol ester transfer protein and LDL receptor. Prostaglandins Leukotrienes Essent Fatty Acids 2013; 88: 281–288.
Griffin BA. The effect of n−3 fatty acids on low density lipoprotein subfractions. Lipids 2001; 36: S91–S97.
Jackson KG, Maitin V, Leake DS, Yaqoob P, Williams CM. Saturated fat-induced changes in Sf 60–400 particle composition reduces uptake of LDL by HepG2 cells. J Lipid Res 2006; 47: 393–403.
Olano-Martin E, Anil E, Caslake MJ, Packard CJ, Bedford D, Stewart G et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 2010; 209: 104–110.
Lee MW, Park JK, Hong JW, Kim KJ, Shin DY, Ahn CW et al. Beneficial effects of Omega-3 fatty acids on low density lipoprotein particle size in patients with type 2 diabetes already under Statin Therapy. Diabetes Metab J 2013; 37: 207–211.
Hirayama S, Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta 2012; 414: 215–224.
Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC Jr et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007; 192: 211–217.
Bergeron N, Havel RJ. Influence of diets rich in saturated and Omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoproteins B-48, B-100, E, and lipids in triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 1995; 15: 2111–2121.
Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L et al. Effects of n−6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012; 95: 1003–1012.
Dias CB, Garg R, Wood LG, Garg ML. Saturated fat consumption may not be the main cause of increased blood lipid levels. Med Hypotheses 2014; 82: 187–195.